← Back to Clinical Trials
Recruiting NCT07211750

NCT07211750 Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07211750
Status Recruiting
Phase
Sponsor KU Leuven
Condition Multimorbidity
Study Type INTERVENTIONAL
Enrollment 82 participants
Start Date 2025-10-01
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
integrated care intervention tailored to the needs of older adults leaving at home with mood disorders and multimorbidity in Leuven

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 82 participants in total. It began in 2025-10-01 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if I-CONNECT (Integrated Care for Older Adults with Major Depression and Physical Multimorbidity) can improve the health and well-being of older adults with depression or bipolar disorder and at least two chronic physical conditions, such as diabetes or high blood pressure. It will also study if the care model improves how people experience their care, lowers treatment burden, and how well the program is delivered. Researchers will compare two groups: I-CONNECT group: participants receive care coordination, a personalized care plan, medication review, shared decision-making support, and regular follow-up from a care coordinator working with their GP, psychiatrist, pharmacist, and specialists. Usual care group: participants continue with their normal healthcare from their GP and psychiatrist. Participants will: Receive either I-CONNECT or usual care, depending on their group Complete questionnaires about their mood, quality of life, and care experience Have their healthcare use (emergency visits and hospitalizations) tracked during the study

Eligibility Criteria

Inclusion Criteria: * Age 65 years or older * Clinical diagnosis of a mood disorder (depression or bipolar disorder) * Currently receiving care from a psychiatrist * At least two chronic physical health conditions * Living independently at home in the Leuven region * Ongoing care from both a general practitioner and a psychiatrist Exclusion Criteria: * Severe cognitive impairment (e.g., advanced dementia) that prevents participation in assessments or shared decision-making * Inability to provide informed consent

Contact & Investigator

Central Contact

Louise de Almeida Ferreira Fonseca

✉ louise.dealmeidaferreira@kuleuven.be

📞 +32 16 37 66 21

Frequently Asked Questions

Who can join the NCT07211750 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Multimorbidity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07211750 currently recruiting?

Yes, NCT07211750 is actively recruiting participants. Contact the research team at louise.dealmeidaferreira@kuleuven.be for enrollment information.

Where is the NCT07211750 trial being conducted?

This trial is being conducted at Leuven, Belgium.

Who is sponsoring the NCT07211750 clinical trial?

NCT07211750 is sponsored by KU Leuven. The trial plans to enroll 82 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology